I agree that this site is using cookies. You can find further informations here.
X
Massard, Christophe
492  results:
Search for persons X
?
1

Reactions and adverse events induced by T-cell engagers as ..:

Géraud, Arthur ; Hueso, Thomas ; Laparra, Ariane...
European Journal of Cancer.  205 (2024)  - p. 114075 , 2024
Link: https://doi.org/10.1016/..
 
?
2

Molecular profiling of biliary tract cancers reveals distin..:

Astier, Clémence ; Ngo, Carine ; Colmet-Daage, Léo...
Experimental Hematology & Oncology.  13 (2024)  1 - p. , 2024
Link: https://doi.org/10.1186/..
 
?
3

Theragnostic Gadolinium-Based Nanoparticles Safely Augment ..:

Chargari, Cyrus ; Maury, Pauline ; Texier, Matthieu...
ACS Nano.  , 2024
Link: https://doi.org/10.1021/..
 
?
4

An international phase II trial and immune profiling of SBR..:

Levy, Antonin ; Morel, Daphné ; Texier, Matthieu...
Molecular Cancer.  23 (2024)  1 - p. , 2024
Link: https://doi.org/10.1186/..
 
?
5

A Score to Predict the Clinical Usefulness of Therapeutic D..:

Géraud, Arthur ; Combarel, David ; Funck‐Brentano, Christian...
Clinical Pharmacology & Therapeutics.  , 2024
Link: https://doi.org/10.1002/..
 
?
6

Antibody drug conjugates in older patients: State of the ar:

Rached, Layal ; Geraud, Arthur ; Frelaut, Maxime...
Critical Reviews in Oncology/Hematology.  193 (2024)  - p. 104212 , 2024
Link: https://doi.org/10.1016/..
 
?
7

Development of Novel Models of Aggressive Variants of Castr..:

Bigot, Ludovic ; Sabio, Jonathan ; Poiraudeau, Loic...
European Urology Oncology.  7 (2024)  3 - p. 527-536 , 2024
Link: https://doi.org/10.1016/..
 
?
8

Meta-analysis and Critical Review: Association Between Radi..:

El Houat, Yasmine ; Massard, Christophe ; Quillien, Veronique..
Advances in Radiation Oncology.  8 (2023)  2 - p. 101038 , 2023
Link: https://doi.org/10.1016/..
 
?
9

Safety Profile of Ipatasertib Plus Abiraterone vs Placebo P..:

Matsubara, Nobuaki ; de Bono, Johann ; Sweeney, Christopher...
Clinical Genitourinary Cancer.  21 (2023)  2 - p. 230-237.e1 , 2023
Link: https://doi.org/10.1016/..
 
?
10

Corrigendum to "Pembrolizumab plus Olaparib in Patients wit..:

Yu, Evan Y. ; Piulats, Josep M. ; Gravis, Gwenaelle...
European Urology.  83 (2023)  3 - p. e87 , 2023
Link: https://doi.org/10.1016/..
 
?
11

Pembrolizumab plus Olaparib in Patients with Metastatic Cas..:

Yu, Evan Y. ; Piulats, Josep M. ; Gravis, Gwenaelle...
European Urology.  83 (2023)  1 - p. 15-26 , 2023
Link: https://doi.org/10.1016/..
 
?
12

CTNI-64. EFFICACY AND SAFETY OF ERDAFITINIB IN PATIENTS WIT..:

Reardon, David ; Welsh, Liam ; Shih, Kent...
Neuro-Oncology.  25 (2023)  Supplement_5 - p. v91-v91 , 2023
Link: https://doi.org/10.1093/..
 
?
13

Sequence analyses of relapsed or refractory diffuse large B..:

Michot, Jean‐Marie ; Quivoron, Cyril ; Sarkozy, Clémentine...
American Journal of Hematology.  98 (2023)  4 - p. 645-657 , 2023
Link: https://doi.org/10.1002/..
 
?
14

Outcome of adrenocortical carcinoma patients included in ea..:

Hescot, Ségolène ; Debien, Véronique ; Hadoux, Julien...
European Journal of Cancer.  189 (2023)  - p. 112917 , 2023
Link: https://doi.org/10.1016/..
 
?
15

Molecular analysis for refractory rare cancers: Sequencing ..:

Debien, Véronique ; Vignot, Stéphane ; Massard, Christophe...
Critical Reviews in Oncology/Hematology.  181 (2023)  - p. 103888 , 2023
Link: https://doi.org/10.1016/..
 
1-15